OJIM  Vol.3 No.1 , March 2013
Association of a cytosine-adenine repeat polymorphism in the estrogen receptor β gene with occurrence and severity of rheumatoid arthritis
Abstract: We investigated the influence of the cytosine-adenine (CA) dinucleotide repeat polymorphism in intron 6 of estrogen receptor β (ERβ) gene on rheumatoid arthritis (RA) risk. One hundred and ninety-three RA patients and 77 control subjects with osteoarthritis (OA) were recruited. The CA repeat polymorphism was assayed by a dye-terminator cycle sequencing analysis. No statistically significant difference in the mean number of CA repeats between the RA and OA patients was observed (RA: 21.47, OA: 21.23, P = 0.324). The alleles were categorized according to the number of repeats: short (S, ≦21) and long (L, ≧22), in which the genotypes SS, SL, and LL were observed. No significant differences were observed for the allele and genotype distributions of this polymorphism in both patient groups. The RA patients were classified according to RA severity: mild (least erosive disease) and severe (more erosive and mutilating disease). Again, no significant difference in genotype frequency between these groups was observed, even after stratifying by sex. The present study indicates that additional studies are needed to clarify the roles of this polymorphism, estrogen, and ER in the development of autoimmune diseases.
Cite this paper: Watanabe, K. , Sato, H. , Ito, A. , Sato, T. , González-Canga, A. , Sugai, H. , Suzuki, M. , Namiki, T. and Ueno, K. (2013) Association of a cytosine-adenine repeat polymorphism in the estrogen receptor β gene with occurrence and severity of rheumatoid arthritis. Open Journal of Internal Medicine, 3, 3-7. doi: 10.4236/ojim.2013.31002.

[1]   Harle, P., Bongartz, T., Scholmerich, J., Müller-Ladner, U. and Straub, R.H. (2005) Predictive and potentially predictive factors in early arthritis: A multidisciplinary approach. Rheumatology (Oxford), 44, 426-433. doi:10.1093/rheumatology/keh530

[2]   Klareskog, L., Catrina, A.I. and Paget, S. (2009) Rheumatoid arthritis. Lancet, 373, 659-672. doi:10.1016/S0140-6736(09)60008-8

[3]   Whitacre, C.C. (2001) Sex differences in autoimmune disease. Nature Immunology, 2, 777-780. doi:10.1038/ni0901-777

[4]   Cutolo, M., Straub, R.H. and Bijlsma, J.W. (2007) Neuroendocrine-immune interactions in synovitis. Nature Clinical Practice. Rheumatology, 3, 627-634. doi:10.1038/ncprheum0601

[5]   Nelson, J.L. and Ostensen, M. (1997) Pregnancy and rheumatoid arthritis. Rheumatic Diseases Clinics of North America, 23, 195-212. doi:10.1016/S0889-857X(05)70323-9

[6]   Kuiper, S., van Gestel, A.M., Swinkels, H.L., de Boo, T.M., da Silva, J.A. and van Riel, P.L. (2001) Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. The Journal of Rheumatology, 28, 1809-1816.

[7]   Mosselman, S., Polman, J. and Dijkema, R. (1996) ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Letters, 392, 49-53. doi:10.1016/0014-5793(96)00782-X

[8]   Dietrich, W., Haitel, A., Holzer, G., Huber, J.C., Kolbus, A. and Tschugguel, W. (2006) Estrogen receptor-β is the predominant estrogen receptor subtype in normal human synovia. Journal of the Society for Gynecologic Investigation, 13, 512-517.

[9]   Ishizuka, M., Hatori, M., Suzuki, T., Miki, Y., Darnel, A.D., Tazawa, C., Sawai, T., Uzuki, M., Tanaka, Y., Kokubun, S. and Sasano, H. (2004) Sex steroid receptors in rheumatoid arthritis. Clinical Science, 106, 293-300. doi:10.1042/CS20030317

[10]   Fytili, P., Giannatou, E., Papanikolaou, V., Stripeli, F., Karachalios, T., Malizos, K. and Tsezou, A. (2005) Association of repeat polymorphisms in the estrogen receptors α, β, and androgen receptor genes with knee osteoarthritis. Clinical Genetics, 68, 268-277. doi:10.1111/j.1399-0004.2005.00495.x

[11]   Shearman, A.M., Karasik, D., Gruenthal, K.M., Demissie, S., Cupples, L.A., Housman, D.E. and Kiel, D.P. (2004) Estrogen receptor beta polymorphisms are associated with bone mass in women and men: The Framingham Study. Journal of Bone and Mineral Research, 19, 773-781. doi:10.1359/jbmr.0301258

[12]   Negishi, E., Takeo, C., Nakajima, A., Hisamitsu, K., Amano, K., Hirai, A. and Ueno, K. (2006) Analysis of correlation between prescription drugs for climacteric disorders and CA repeat polymorphism of estrogen receptor β gene. Japanese Journal of Pharmaceutical Health Care and Sciences, 32, 21-26. doi:10.5649/jjphcs.32.21

[13]   Gonzalez-Canga, A., Ugai, K., Okuzawa, H., Suzuki, M., Okuzawa, H., Negishi, E. and Uneo, K. (2010) Association of cytosin-adenine repeat polymorphism of the estrogen reseptor-β gene withrheumatoid arthritis symptoms. Rheumatology International, 30, 1259-1262. doi:10.1007/s00296-010-1423-4

[14]   Sato, H., Ito, A., González-Canga, A., Okuzawa, H., Ugai, K., Suzuki, M., Namiki, T. and Ueno, K. (2011) Association of Rsa polymorphism of the estrogen receptor-β gene with rheumatoid arthritis. Rheumatology International, 32, 2143-2148. doi:10.1007/s00296-011-1947-2

[15]   Ochi, T., Iwase, R., Yonemasu, K., Matsukawa, M., Yoneda, M., Yukioka, M. and Ono, K. (1988) Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis. Arthritis and Rheumatism, 31, 37-43. doi:10.1002/art.1780310106

[16]   Wang, J., Nuite, M. and McAlindon, T.E. (2010) Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus. Lupus, 19, 734-740. doi:10.1177/0961203309359517

[17]   Oliver, J.E. and Silman, A.J. (2009) Why are women predisposed to autoimmune rheumatic diseases? Arthritis Research & Therapy, 11, 252. doi:10.1186/ar2825

[18]   Dziedziejko, V., Kurzawski, M., Safranow, K., Drozdzik, M., Chlubek, D. and Pawlik, A. (2011) Oestrogen recaptor polymorphisms in female patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology, 40, 329-333. doi:10.3109/03009742.2011.563752

[19]   Dziedziejko, V., Kurzawski, M., Safranow, K., Chlubek, D. and Pawlik, A. (2011) The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide. Pharmacogenomics, 12, 41-47. doi:10.2217/pgs.10.164

[20]   Engdahl, C., Jochems, C., Windahl, S.H., Borjesson, A.E., Ohlsson, C., Carlsten, H. and Lagerquist, M.K. (2010) Amelioration of collagen-induced arthritis and immuneassociated bone loss through signaling via estrogen receptor, and not estrogen receptor or G protein-coupled receptor 30. Arthritis and Rheumatism, 62, 524-533.

[21]   Cvoro, A., Tatomer, D., Tee, M.K., Zogovic, T., Harris, H.A. and Leitman, D.C. (2008) Selective estrogen recaptor-beta agonists repress transcription of proinflammatory genes. Journal of Immunology, 180, 630-636.

[22]   Roman-Blas, J.A., Castaneda, S., Cutolo, M. and HerreroBeaumont, G. (2010) Efficacy and safety of a selective estrogen receptor agonist, ERB-041, in patients with rheumatoid arthritis: A 12-week, randomized, placebo-controlled, phase II Study. Arthritis Care & Research, 62, 1588-1593. doi:10.1002/acr.20275

[23]   Walitt, B., Pettinger, M., Weinstein, A., Katz, J., Torner, J., Wasko, M.C., Howard, B.V. and Women’s Health Initiative Investigators (2008) Effects of postmenopausal hormone therapy on rheumatoid arthritis: The women’s health initiative randomized controlled trials. Arthritis and Rheumatism, 59, 302-310. doi:10.1002/art.23325

[24]   Ganesan, K., Balachandran, C., Manohar, B.M. and Puvanakrishnan, R. (2011) Effects of testosterone, estrogen and progesterone on TNF-α mediated cellular damage in rat arthritic synovial fibroblasts. Rheumatology International, 32, 3181-3188. doi:10.1007/s00296-011-2146-x

[25]   Karlson, E.W., Chibnik, L.B., McGrath, M., Chang, S.-C., Keenan, B.T., Costenbader, K.H., Fraser, P.A., Tworoger, S., Hankinson, S.E., Lee, I.-M., Buring, J. and De Vivo, I. (2009) A prospective study of androgen levels, hormonerelated genes and risk of rheumatoid arthritis. Arthritis Research & Therapy, 11, R97. doi:10.1186/ar2742